Patent · US Active

3-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the treatment of type 1 and type 2 diabetes

US8153649B2 · kind B2 · utility

2Cited by

0References

27Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Markus Klein · Weiterstadt, DE
Rolf Gericke · Seeheim-Jugenheim, DE
Norbert Beier · Reinheim, DE
Bertram Cezanne · Mörfelden, DE
Christos Tsaklakidis · Weinheim, DE
Werner Mederski · Zwingenberg, DE

Key dates

Filing date	Sep 27, 2007
Grant date	Apr 10, 2012
Priority date	—
Expiry date	Aug 15, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P3/10
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Novel compounds of the formula (I), in which W, T, R1, R2, R3, R4, R5 and R6 have the meanings indicated in Patent Claim (1), are suitable as antidiabetics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.